title: Uterine rupture during therapeutic abortion in the second trimester using mifepristone and prostaglandin.
authors.forename: K J
authors.initials: KJ
authors.lastname: Thong
authors.forename: P
authors.initials: P
authors.lastname: Lynch
authors.forename: D T
authors.initials: DT
authors.lastname: Baird
mesh_terms: D000020:Abortifacient Agents, Nonsteroidal / Q000009:adverse effects*; D000021:Abortifacient Agents, Steroidal / Q000009:adverse effects*; D000032:Abortion, Therapeutic; D000527:Alprostadil / Q000009:adverse effects / Q000031:analogs & derivatives*; D005260:Female; D006801:Humans; D015735:Mifepristone / Q000009:adverse effects*; D011247:Pregnancy; D011262:Pregnancy Trimester, Second; D014597:Uterine Rupture / Q000139:chemically induced*
chemical_list: D000020:Abortifacient Agents, Nonsteroidal; D000021:Abortifacient Agents, Steroidal; D015735:Mifepristone; C021182:gemeprost; D000527:Alprostadil